CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19+ Relapsed/Refractory Malignancies

MLA

Miquel Lozano, et al. “CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19+ Relapsed/Refractory Malignancies.” Molecular Therapy, vol. 29, Feb. 2021, pp. 636–44. EBSCOhost, https://doi.org/10.1016/j.ymthe.2020.09.027.

APA

Miquel Lozano, Iolanda Jordan, Enric Garcia-Rey, Manel Juan, Miguel Caballero-Baños, Laia Guardia, Pedro Castro, E. Azucena González, Andrea Scalise, Eva Giné, Jordi Esteve, Ferran Torres, Neus Villamor, Esteve Trias, Alvaro Urbano-Ispizua, Marina Díaz-Beyá, Julio Delgado, Cristina Llanos, Sara Fernández, … Guillermo Suñe. (2021). CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19+ Relapsed/Refractory Malignancies. Molecular Therapy, 29, 636–644. https://doi.org/10.1016/j.ymthe.2020.09.027

Chicago

Miquel Lozano, Iolanda Jordan, Enric Garcia-Rey, Manel Juan, Miguel Caballero-Baños, Laia Guardia, Pedro Castro, et al. 2021. “CART19-BE-01: A Multicenter Trial of ARI-0001 Cell Therapy in Patients with CD19+ Relapsed/Refractory Malignancies.” Molecular Therapy 29 (February): 636–44. doi:10.1016/j.ymthe.2020.09.027.